Idera announces FDA orphan drug designation for IMO-8400 for the treatment of diffuse large B-cell lymphoma
2 April 2015 | By Victoria White
Idera has announced that the FDA has granted orphan drug designation for IMO-8400 for the treatment of diffuse large B-cell lymphoma (DLBCL)...